- Home
- DAWN vs OXM Comparison
DAWN vs OXM Comparison
Compare DAWN & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- OXM
- Stock Information
- Founded
- DAWN 2018
- OXM 1942
- Country
- DAWN United States
- OXM United States
- Employees
- DAWN N/A
- OXM N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- OXM Apparel
- Sector
- DAWN Health Care
- OXM Consumer Discretionary
- Exchange
- DAWN Nasdaq
- OXM Nasdaq
- Market Cap
- DAWN 624.8M
- OXM 672.2M
- IPO Year
- DAWN 2021
- OXM N/A
- Fundamental
- Price
- DAWN $7.20
- OXM $46.98
- Analyst Decision
- DAWN Strong Buy
- OXM Hold
- Analyst Count
- DAWN 7
- OXM 6
- Target Price
- DAWN $27.86
- OXM $55.80
- AVG Volume (30 Days)
- DAWN 2.1M
- OXM 317.6K
- Earning Date
- DAWN 08-05-2025
- OXM 09-10-2025
- Dividend Yield
- DAWN N/A
- OXM 5.87%
- EPS Growth
- DAWN N/A
- OXM 100.54
- EPS
- DAWN N/A
- OXM 5.14
- Revenue
- DAWN $187,638,000.00
- OXM $1,511,278,000.00
- Revenue This Year
- DAWN $16.42
- OXM $0.49
- Revenue Next Year
- DAWN $47.52
- OXM $1.90
- P/E Ratio
- DAWN N/A
- OXM $9.15
- Revenue Growth
- DAWN 2190.50
- OXM N/A
- 52 Week Low
- DAWN $5.64
- OXM $36.25
- 52 Week High
- DAWN $16.76
- OXM $89.86
- Technical
- Relative Strength Index (RSI)
- DAWN 62.39
- OXM 62.11
- Support Level
- DAWN $6.71
- OXM $43.28
- Resistance Level
- DAWN $7.12
- OXM $46.84
- Average True Range (ATR)
- DAWN 0.32
- OXM 1.75
- MACD
- DAWN 0.10
- OXM 0.70
- Stochastic Oscillator
- DAWN 85.05
- OXM 91.63
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.